Abbott Laboratories (ABT) Debt by Year
Abbott Laboratories carried $9.9B in long-term debt against $8.5B in cash and equivalents at the end of fiscal year 2025. Long-term debt fell 21.6% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Abbott Laboratories has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ABT Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $9.9B-21.6% | $12.6B-7.2% | $13.6B-6.4% | $14.5B-16.0% | $17.3B-6.6% | $18.5B+11.2% | $16.7B-13.9% | $19.4B-28.9% | $27.2B+31.6% | $20.7B+252.3% | $5.9B+73.0% | $3.4B+0.1% | $3.4B-81.3% | $18.1B+50.2% | $12.0B |
| Cash & Equivalents | $8.5B+11.9% | $7.6B+10.4% | $6.9B-30.2% | $9.9B+0.8% | $9.8B+43.3% | $6.8B+77.2% | $3.9B+0.4% | $3.8B-59.1% | $9.4B-49.5% | $18.6B+272.3% | $5.0B+23.1% | $4.1B+16.9% | $3.5B-67.8% | $10.8B+58.5% | $6.8B |
ABT Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $29.6B+128.9% | $29.6B+132.7% | $9.9B-21.6% | $11.6B-9.6% | $12.9B-1.6% | $12.7B+1.3% | $12.6B-7.2% | $12.8B-11.4% | $13.1B-9.8% | $12.6B-14.0% | $13.6B-6.4% | $14.5B-5.4% |
| Cash & Equivalents | $5.1B-26.6% | $6.8B+4.1% | $8.5B+11.9% | $7.5B-0.6% | $7.0B-0.5% | $6.5B+3.9% | $7.6B+10.4% | $7.6B+12.7% | $7.0B-10.8% | $6.3B-31.4% | $6.9B-30.2% | $6.7B-30.1% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Abbott Laboratories financials
Frequently Asked Questions
What was Abbott Laboratories's long-term debt in fiscal year 2025?
Abbott Laboratories carried $9.9B in long-term debt against $8.5B in cash and equivalents at the end of fiscal year 2025.
How fast is Abbott Laboratories's long-term debt growing?
Abbott Laboratories (ABT) long-term debt fell by 21.6% year over year, from $12.6B to $9.9B in fiscal year 2025.
How has Abbott Laboratories's long-term debt changed over the years?
Across the 15 fiscal years this page covers, Abbott Laboratories (ABT) long-term debt went from $12.0B in fiscal year 2011 to $9.9B in fiscal year 2025.
What was Abbott Laboratories's long-term debt in the most recent quarter?
Abbott Laboratories (ABT) reported $29.6B in long-term debt in Q2 2026. This represents an increase of 128.9% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Abbott Laboratories (ABT) reported on that line in every period on record.